EMFAT
MGNX icon

Emerald Mutual Fund Advisers Trust’s MacroGenics MGNX Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-358,161
Closed -$6.62M – 258
2017
Q3 		$6.62M Hold
358,161
– – 0.28% 124
2017
Q2 		$6.27M Hold
358,161
– – 0.27% 125
2017
Q1 		$6.66M Hold
358,161
– – 0.3% 113
2016
Q4 		$7.32M Hold
358,161
– – 0.35% 104
2016
Q3 		$10.7M Buy
358,161
+37,190
+12% +$1.11M 0.55% 75
2016
Q2 		$8.66M Sell
320,971
-204,525
-39% -$4.61M 0.49% 80
2016
Q1 		$9.85M Buy
525,496
+44,114
+9% +$840K 0.55% 71
2015
Q4 		$14.9M Buy
481,382
+136,174
+39% +$4.14M 0.79% 44
2015
Q3 		$7.39M Buy
345,208
+65,000
+23% +$2.04M 0.48% 81
2015
Q2 		$10.6M Sell
280,208
-37,720
-12% -$1.24M 0.82% 44
2015
Q1 		$10.2M Sell
317,928
-5,000
-2% -$169K 0.83% 47
2014
Q4 		$11.3M Buy
322,928
+111,971
+53% +$2.79M 0.98% 33
2014
Q3 		$4.41M Buy
210,957
+1,500
+0.7% +$31K 0.42% 85
2014
Q2 		$4.55M Buy
209,457
+8,580
+4% +$180K 0.42% 90
2014
Q1 		$5.59M Sell
200,877
-99,055
-33% -$3.5M 0.53% 72
2013
Q4 		$9.75M Buy
+299,932
New +$7.85M 0.58% 68

Other funds holding MGNX

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's MGNX Position: Q4 2017 in Review

Emerald Mutual Fund Advisers Trust sold out of MacroGenics (MGNX) in Q4 2017, closing a stake of 358,161 shares — an estimated $6.62M sold.

Emerald Mutual Fund Advisers Trust first reported a position in MGNX in Q4 2013 and held it in 16 quarters. The position peaked at $14.9M in Q4 2015. 119 funds tracked by Wall St. Rank hold MGNX as of Q4 2017.

  • Emerald Mutual Fund Advisers Trust reported no remaining MacroGenics position as of Q4 2017 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 358,161 MacroGenics shares in Q4 2017, an estimated $6.62M.
  • Emerald Mutual Fund Advisers Trust first reported a position in MacroGenics in Q4 2013 and held it in 16 quarters.
  • Emerald Mutual Fund Advisers Trust's MacroGenics position peaked at $14.9M in Q4 2015.
  • 119 funds tracked by Wall St. Rank held MacroGenics as of Q4 2017.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q4 2017, filed 6 Feb 2018.